Saturday 17 October 2026
Export AEMD’s income statement to Excel — free account
Aethlon Medical, Inc.
AEMD Healthcare Medical Devices
Aethlon Medical, Inc.’s revenue for fiscal 2023 (year ended March 2023) was $574,200.00, up 95.2% from fiscal 2022. In the quarter to June 2026, EPS grew 90.5% and free cash flow fell 11.1%, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
5.15
0.12
−2.28%
Follow AEMD
| Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 | Mar '19 | Mar '18 | Mar '17 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Piotroski F-Score |
— | — | — | 5 | 4 | 3 | 5 | 4 | 4 | 3 |
Altman Z-Score |
— | — | — | (10.76) | (4.80) | (6.48) | (12.93) | (34.35) | (13.49) | (76.38) |
P/S ratio |
— | — | — | 10.53 | 73.45 | 19.04 | 7.49 | 42.25 | 31.28 | 32.88 |
Altman Z″-Score (non-manufacturers) |
— | — | — | (19.51) | (12.62) | (29.00) | (24.55) | (88.47) | (37.69) | (196.52) |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
P/Operating CF |
— | — | — | (2.63) | (6.97) | (10.88) | (3.38) | (11.46) | (16.50) | (20.57) |
Beneish M-Score |
— | — | — | — | (1.77) | (3.40) | — | — | — | — |
P/B ratio |
— | — | — | 0.51 | 1.27 | 2.62 | 0.59 | 6.97 | 2.78 | 32.95 |
Price to Tangible BV |
— | — | — | 0.51 | 1.27 | 2.64 | 0.59 | 7.18 | 2.82 | 38.44 |
EV/Sales |
— | — | — | (8.02) | 18.38 | 12.01 | (4.47) | 34.45 | 19.86 | 31.14 |
EV/EBITDA |
— | — | — | 0.48 | 0.00 | 0.00 | 0.56 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | 0.56 | (0.55) | (2.27) | 0.63 | (3.04) | (2.73) | (5.30) |
EV/FCF |
— | — | — | 0.52 | (0.53) | (2.25) | 0.61 | (3.03) | (2.71) | (5.27) |
Quick Ratio |
3.47 | 2.90 | 2.97 | 9.66 | 9.43 | 7.28 | 9.19 | 2.10 | 14.75 | 2.55 |
Current Ratio |
3.85 | 3.13 | 3.40 | 10.03 | 9.95 | 7.53 | 9.40 | 2.21 | 15.13 | 2.61 |
Net Debt/EBITDA |
0.72 | 0.61 | 0.44 | 1.25 | 1.66 | 1.26 | 1.64 | 0.65 | 1.35 | 0.18 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 11.44% | 30.07% |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.14 | 0.87 |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.03 | 0.02 | 0.06 | 0.09 | 0.04 | 0.03 | 0.18 |
Operating CF/Net income |
0.98 | 0.57 | 0.83 | 0.87 | 0.94 | 0.86 | 0.82 | 0.69 | 0.69 | 0.48 |
Capex/Depreciation |
(0.01) | 0.00 | (0.70) | (3.91) | (2.26) | (1.60) | (2.68) | 0.00 | (0.09) | (0.06) |
Interest Coverage |
(506.50) | (924.89) | — | (1,081.69) | — | (4,932.19) | (109.41) | (27.21) | (13.36) | (20.04) |
| (142.89%) | (245.88%) | (117.21%) | (75.06%) | (79.25%) | (84.94%) | (110.12%) | (148.70%) | (171.38%) | (693.69%) | |
| (104.46%) | (171.58%) | (94.80%) | (65.15%) | (69.24%) | (74.91%) | (87.85%) | (107.97%) | (125.12%) | (341.96%) | |
ROIC |
0.00% | 0.00% | (2,435.36%) | (1,399.70%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
(159.65%) | (283.24%) | (225.61%) | (81.67%) | (62.10%) | (86.31%) | (69.94%) | (279.02%) | (83.77%) | (717.07%) |
Average Days of Receivables |
— | — | — | 0.00 | 158.80 | 82.57 | 116.03 | 0.00 | 182.50 | 0.00 |
Research and Development Expense of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 2,172.22% | 3,642.11% | 1,297.31% | 1,012.03% | 2,712.80% | 3,329.34% | 1,655.29% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.02 | 0.01 | 0.05 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 183.19% | 255.13% | 118.25% | 129.81% | 574.48% | 842.78% | 557.59% |
Graham Net Nets |
— | — | — | 1.63 | 0.73 | 0.37 | 1.63 | 0.14 | 0.35 | 0.02 |
Graham Number |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | — | — | (157.89%) | (47.95%) | (32.02%) | (123.65%) | (38.18%) | (34.98%) | (28.83%) |
Free Cash Flow Yield |
— | — | — | (147.68%) | (46.82%) | (28.02%) | (97.76%) | (26.96%) | (23.43%) | (17.95%) |
Revenue per Share |
0.00 | 0.00 | 0.00 | 112.59 | 79.51 | 219.70 | 722.44 | 765.33 | 748.00 | 3,921.00 |
Operating CF per Share |
(51.92) | (245.05) | (1,607.90) | (2,059.82) | (2,639.78) | (2,254.97) | (5,775.11) | (14,311.33) | (19,553.50) | (35,059.00) |
Capex per Share |
(0.03) | 0.00 | (39.83) | (184.92) | (94.38) | (19.97) | (168.56) | 0.00 | (124.00) | (164.00) |
Free Cash Flow per Share |
(51.94) | (245.05) | (1,647.73) | (2,244.75) | (2,734.16) | (2,274.93) | (5,943.67) | (14,311.33) | (19,677.50) | (35,223.00) |
Cash per Share |
37.29 | 176.32 | 863.81 | 2,849.59 | 4,614.16 | 3,287.20 | 10,672.00 | 12,760.33 | 34,870.50 | 15,597.00 |
Shareholders Equity per Share |
36.25 | 164.21 | 915.29 | 2,953.76 | 4,592.27 | 3,097.90 | 10,308.22 | 7,663.67 | 30,164.00 | 5,954.00 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
Book value per Share |
36.25 | 164.21 | 915.29 | 2,953.76 | 4,592.27 | 3,097.90 | 10,308.22 | 7,663.67 | 30,164.00 | 5,954.00 |
Free Cash Flow |
(7.00) | (7.65) | (10.38) | (11.45) | (10.12) | (6.82) | (5.35) | (4.29) | (3.94) | (3.52) |
Working Capital |
4.12 | 4.05 | 4.40 | 13.59 | 16.33 | 8.98 | 8.97 | 2.21 | 6.75 | 0.99 |
Capital Expenditures |
0.00 | — | (0.25) | (0.94) | (0.35) | (0.06) | (0.15) | — | (0.02) | (0.02) |
Net Current Asset Value |
4.12 | 3.71 | 3.75 | 12.65 | 15.73 | 8.98 | 8.93 | 2.21 | 5.91 | 0.47 |
EV/EBIT |
— | — | — | 0.50 | 0.00 | 0.00 | 0.55 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
0.00 | — | 0.00 | 1.64 | 1.19 | 0.09 | 0.23 | 0.00 | 0.17 | 0.04 |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.91 | 0.50 | 0.35 | 0.21 | 0.35 | 0.23 | 0.40 | 25.30 | 10.19 | 8.66 |
Cash ROIC |
(70.64%) | (71.96%) | (92.62%) | (38.68%) | (29.70%) | (35.63%) | (28.33%) | (70.07%) | (28.42%) | (131.71%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 2.12 | 3.70 | 4.62 | 0.00 | 1.09 | 0.00 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | 0.00 | — | — | — | — | — |
Average Receivables |
— | — | — | — | 0.14 | 0.18 | 0.14 | — | 0.14 | — |
Average Payables |
0.46 | 0.66 | 0.61 | 0.47 | 0.42 | 0.31 | 0.21 | 0.13 | 0.30 | 0.36 |
Average Assets |
6.85 | 7.80 | 12.88 | 18.46 | 15.04 | 10.53 | 7.26 | 5.74 | 4.54 | 2.13 |
Average Common Equity |
5.00 | 5.44 | 10.42 | 16.03 | 13.14 | 9.29 | 5.79 | 4.17 | 3.31 | 1.05 |
Columns are period end dates